Click for best price
Cell Gene Therapy Manufacturing Services Market Size, Share 2023
Gene therapy aims to treat disorders by replacing or introducing genes into cells? either inside the body (in vivo) or outside of the body (ex vivo).
This report aims to provide a comprehensive presentation of the global market for Cell and Gene Therapy Manufacturing Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell and Gene Therapy Manufacturing Services. This report contains market size and forecasts of Cell and Gene Therapy Manufacturing Services in global, including the following market information:
Global Cell and Gene Therapy Manufacturing Services Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Cell and Gene Therapy Manufacturing Services market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
By Cell Therapy Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cell and Gene Therapy Manufacturing Services include Thermo Fisher Scientific, Merck KGaA, Charles River Laboratories, Lonza, Catalent, WuXi AppTec, Takara Bio Inc, Nikon Corporation and FUJIFILM Holdings Corporation, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Wesurveyed the Cell and Gene Therapy Manufacturing Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell and Gene Therapy Manufacturing Services Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Type, 2022 (%)
By Cell Therapy
Allogeneic
Autologous
Viral Vector
By Gene Therapy
Non-viral Vector
Oligonucleotides
Viral Vector
Global Cell and Gene Therapy Manufacturing Services Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, by Application, 2022 (%)
Oncology Diseases
Cardiovascular Diseases
Orthopedic Diseases
Ophthalmology Diseases
Infectious Diseases
Others
Global Cell and Gene Therapy Manufacturing Services Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Cell and Gene Therapy Manufacturing Services Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell and Gene Therapy Manufacturing Services revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Cell and Gene Therapy Manufacturing Services revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck KGaA
Charles River Laboratories
Lonza
Catalent
WuXi AppTec
Takara Bio Inc
Nikon Corporation
FUJIFILM Holdings Corporation
F. Hoffmann-La Roche
Oxford Biomedica Plc
Cell and Gene Therapy Catapult
The Discovery Labs LLC
RoslinCT
JRS PHARMA
FinVector
ABL
Resilience
BioCentriq
Porton Biopharma Limited
Andelyn Biosciences
Commercializing Living Therapies
Vibalogics
Anemocyte Srl
ElevateBio
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cell and Gene Therapy Manufacturing Services, market overview.
Chapter 2: Global Cell and Gene Therapy Manufacturing Services market size in revenue.
Chapter 3: Detailed analysis of Cell and Gene Therapy Manufacturing Services company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cell and Gene Therapy Manufacturing Services in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Cell and Gene Therapy Manufacturing Services Market, Global Outlook and Forecast 2023-2029 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell and Gene Therapy Manufacturing Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell and Gene Therapy Manufacturing Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell and Gene Therapy Manufacturing Services Overall Market Size
2.1 Global Cell and Gene Therapy Manufacturing Services Market Size: 2022 VS 2029
2.2 Global Cell and Gene Therapy Manufacturing Services Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell and Gene Therapy Manufacturing Services Players in Global Market
3.2 Top Global Cell and Gene Therapy Manufacturing Services Companies Ranked by Revenue
3.3 Global Cell and Gene Therapy Manufacturing Services Revenue by Companies
3.4 Top 3 and Top 5 Cell and Gene Therapy Manufacturing Services Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cell and Gene Therapy Manufacturing Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Players in Global Market
3.6.1 List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cell and Gene Therapy Manufacturing Services Market Size Markets, 2022 & 2029
4.1.2 Allogeneic
4.1.3 Autologous
4.1.4 Viral Vector
4.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
4.2.1 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2018-2023
4.2.2 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, 2024-2029
4.2.3 By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell and Gene Therapy Manufacturing Services Market Size, 2022 & 2029
5.1.2 Oncology Diseases
5.1.3 Cardiovascular Diseases
5.1.4 Orthopedic Diseases
5.1.5 Ophthalmology Diseases
5.1.6 Infectious Diseases
5.1.7 Others
5.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
5.2.1 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2018-2023
5.2.2 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, 2024-2029
5.2.3 By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cell and Gene Therapy Manufacturing Services Market Size, 2022 & 2029
6.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue & Forecasts
6.2.1 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2018-2023
6.2.2 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue, 2024-2029
6.2.3 By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, 2018-2029
6.3.2 US Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.3.3 Canada Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.3.4 Mexico Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, 2018-2029
6.4.2 Germany Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4.3 France Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4.4 U.K. Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4.5 Italy Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4.6 Russia Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4.7 Nordic Countries Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.4.8 Benelux Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, 2018-2029
6.5.2 China Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.5.3 Japan Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.5.4 South Korea Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.5.5 Southeast Asia Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.5.6 India Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, 2018-2029
6.6.2 Brazil Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.6.3 Argentina Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, 2018-2029
6.7.2 Turkey Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.7.3 Israel Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.7.4 Saudi Arabia Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
6.7.5 UAE Cell and Gene Therapy Manufacturing Services Market Size, 2018-2029
7 Cell and Gene Therapy Manufacturing Services Companies Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Company Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.1.4 Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.1.5 Thermo Fisher Scientific Key News & Latest Developments
7.2 Merck KGaA
7.2.1 Merck KGaA Company Summary
7.2.2 Merck KGaA Business Overview
7.2.3 Merck KGaA Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.2.4 Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.2.5 Merck KGaA Key News & Latest Developments
7.3 Charles River Laboratories
7.3.1 Charles River Laboratories Company Summary
7.3.2 Charles River Laboratories Business Overview
7.3.3 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.3.4 Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.3.5 Charles River Laboratories Key News & Latest Developments
7.4 Lonza
7.4.1 Lonza Company Summary
7.4.2 Lonza Business Overview
7.4.3 Lonza Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.4.4 Lonza Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.4.5 Lonza Key News & Latest Developments
7.5 Catalent
7.5.1 Catalent Company Summary
7.5.2 Catalent Business Overview
7.5.3 Catalent Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.5.4 Catalent Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.5.5 Catalent Key News & Latest Developments
7.6 WuXi AppTec
7.6.1 WuXi AppTec Company Summary
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.6.4 WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.6.5 WuXi AppTec Key News & Latest Developments
7.7 Takara Bio Inc
7.7.1 Takara Bio Inc Company Summary
7.7.2 Takara Bio Inc Business Overview
7.7.3 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.7.4 Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.7.5 Takara Bio Inc Key News & Latest Developments
7.8 Nikon Corporation
7.8.1 Nikon Corporation Company Summary
7.8.2 Nikon Corporation Business Overview
7.8.3 Nikon Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.8.4 Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.8.5 Nikon Corporation Key News & Latest Developments
7.9 FUJIFILM Holdings Corporation
7.9.1 FUJIFILM Holdings Corporation Company Summary
7.9.2 FUJIFILM Holdings Corporation Business Overview
7.9.3 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.9.4 FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.9.5 FUJIFILM Holdings Corporation Key News & Latest Developments
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Company Summary
7.10.2 F. Hoffmann-La Roche Business Overview
7.10.3 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.10.4 F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.10.5 F. Hoffmann-La Roche Key News & Latest Developments
7.11 Oxford Biomedica Plc
7.11.1 Oxford Biomedica Plc Company Summary
7.11.2 Oxford Biomedica Plc Business Overview
7.11.3 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.11.4 Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.11.5 Oxford Biomedica Plc Key News & Latest Developments
7.12 Cell and Gene Therapy Catapult
7.12.1 Cell and Gene Therapy Catapult Company Summary
7.12.2 Cell and Gene Therapy Catapult Business Overview
7.12.3 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.12.4 Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.12.5 Cell and Gene Therapy Catapult Key News & Latest Developments
7.13 The Discovery Labs LLC
7.13.1 The Discovery Labs LLC Company Summary
7.13.2 The Discovery Labs LLC Business Overview
7.13.3 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.13.4 The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.13.5 The Discovery Labs LLC Key News & Latest Developments
7.14 RoslinCT
7.14.1 RoslinCT Company Summary
7.14.2 RoslinCT Business Overview
7.14.3 RoslinCT Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.14.4 RoslinCT Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.14.5 RoslinCT Key News & Latest Developments
7.15 JRS PHARMA
7.15.1 JRS PHARMA Company Summary
7.15.2 JRS PHARMA Business Overview
7.15.3 JRS PHARMA Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.15.4 JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.15.5 JRS PHARMA Key News & Latest Developments
7.16 FinVector
7.16.1 FinVector Company Summary
7.16.2 FinVector Business Overview
7.16.3 FinVector Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.16.4 FinVector Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.16.5 FinVector Key News & Latest Developments
7.17 ABL
7.17.1 ABL Company Summary
7.17.2 ABL Business Overview
7.17.3 ABL Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.17.4 ABL Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.17.5 ABL Key News & Latest Developments
7.18 Resilience
7.18.1 Resilience Company Summary
7.18.2 Resilience Business Overview
7.18.3 Resilience Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.18.4 Resilience Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.18.5 Resilience Key News & Latest Developments
7.19 BioCentriq
7.19.1 BioCentriq Company Summary
7.19.2 BioCentriq Business Overview
7.19.3 BioCentriq Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.19.4 BioCentriq Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.19.5 BioCentriq Key News & Latest Developments
7.20 Porton Biopharma Limited
7.20.1 Porton Biopharma Limited Company Summary
7.20.2 Porton Biopharma Limited Business Overview
7.20.3 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.20.4 Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.20.5 Porton Biopharma Limited Key News & Latest Developments
7.21 Andelyn Biosciences
7.21.1 Andelyn Biosciences Company Summary
7.21.2 Andelyn Biosciences Business Overview
7.21.3 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.21.4 Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.21.5 Andelyn Biosciences Key News & Latest Developments
7.22 Commercializing Living Therapies
7.22.1 Commercializing Living Therapies Company Summary
7.22.2 Commercializing Living Therapies Business Overview
7.22.3 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.22.4 Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.22.5 Commercializing Living Therapies Key News & Latest Developments
7.23 Vibalogics
7.23.1 Vibalogics Company Summary
7.23.2 Vibalogics Business Overview
7.23.3 Vibalogics Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.23.4 Vibalogics Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.23.5 Vibalogics Key News & Latest Developments
7.24 Anemocyte Srl
7.24.1 Anemocyte Srl Company Summary
7.24.2 Anemocyte Srl Business Overview
7.24.3 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.24.4 Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.24.5 Anemocyte Srl Key News & Latest Developments
7.25 ElevateBio
7.25.1 ElevateBio Company Summary
7.25.2 ElevateBio Business Overview
7.25.3 ElevateBio Cell and Gene Therapy Manufacturing Services Major Product Offerings
7.25.4 ElevateBio Cell and Gene Therapy Manufacturing Services Revenue in Global Market (2018-2023)
7.25.5 ElevateBio Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell and Gene Therapy Manufacturing Services Market Opportunities & Trends in Global Market
Table 2. Cell and Gene Therapy Manufacturing Services Market Drivers in Global Market
Table 3. Cell and Gene Therapy Manufacturing Services Market Restraints in Global Market
Table 4. Key Players of Cell and Gene Therapy Manufacturing Services in Global Market
Table 5. Top Cell and Gene Therapy Manufacturing Services Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Cell and Gene Therapy Manufacturing Services Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Cell and Gene Therapy Manufacturing Services Revenue Share by Companies, 2018-2023
Table 8. Global Companies Cell and Gene Therapy Manufacturing Services Product Type
Table 9. List of Global Tier 1 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell and Gene Therapy Manufacturing Services Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Cell and Gene Therapy Manufacturing Services Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2024-2029
Table 30. Thermo Fisher Scientific Company Summary
Table 31. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Product Offerings
Table 32. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 33. Thermo Fisher Scientific Key News & Latest Developments
Table 34. Merck KGaA Company Summary
Table 35. Merck KGaA Cell and Gene Therapy Manufacturing Services Product Offerings
Table 36. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 37. Merck KGaA Key News & Latest Developments
Table 38. Charles River Laboratories Company Summary
Table 39. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Product Offerings
Table 40. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 41. Charles River Laboratories Key News & Latest Developments
Table 42. Lonza Company Summary
Table 43. Lonza Cell and Gene Therapy Manufacturing Services Product Offerings
Table 44. Lonza Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 45. Lonza Key News & Latest Developments
Table 46. Catalent Company Summary
Table 47. Catalent Cell and Gene Therapy Manufacturing Services Product Offerings
Table 48. Catalent Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 49. Catalent Key News & Latest Developments
Table 50. WuXi AppTec Company Summary
Table 51. WuXi AppTec Cell and Gene Therapy Manufacturing Services Product Offerings
Table 52. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 53. WuXi AppTec Key News & Latest Developments
Table 54. Takara Bio Inc Company Summary
Table 55. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Product Offerings
Table 56. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 57. Takara Bio Inc Key News & Latest Developments
Table 58. Nikon Corporation Company Summary
Table 59. Nikon Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
Table 60. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 61. Nikon Corporation Key News & Latest Developments
Table 62. FUJIFILM Holdings Corporation Company Summary
Table 63. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Product Offerings
Table 64. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 65. FUJIFILM Holdings Corporation Key News & Latest Developments
Table 66. F. Hoffmann-La Roche Company Summary
Table 67. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Product Offerings
Table 68. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 69. F. Hoffmann-La Roche Key News & Latest Developments
Table 70. Oxford Biomedica Plc Company Summary
Table 71. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Product Offerings
Table 72. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 73. Oxford Biomedica Plc Key News & Latest Developments
Table 74. Cell and Gene Therapy Catapult Company Summary
Table 75. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Product Offerings
Table 76. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 77. Cell and Gene Therapy Catapult Key News & Latest Developments
Table 78. The Discovery Labs LLC Company Summary
Table 79. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Product Offerings
Table 80. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 81. The Discovery Labs LLC Key News & Latest Developments
Table 82. RoslinCT Company Summary
Table 83. RoslinCT Cell and Gene Therapy Manufacturing Services Product Offerings
Table 84. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 85. RoslinCT Key News & Latest Developments
Table 86. JRS PHARMA Company Summary
Table 87. JRS PHARMA Cell and Gene Therapy Manufacturing Services Product Offerings
Table 88. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 89. JRS PHARMA Key News & Latest Developments
Table 90. FinVector Company Summary
Table 91. FinVector Cell and Gene Therapy Manufacturing Services Product Offerings
Table 92. FinVector Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 93. FinVector Key News & Latest Developments
Table 94. ABL Company Summary
Table 95. ABL Cell and Gene Therapy Manufacturing Services Product Offerings
Table 96. ABL Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 97. ABL Key News & Latest Developments
Table 98. Resilience Company Summary
Table 99. Resilience Cell and Gene Therapy Manufacturing Services Product Offerings
Table 100. Resilience Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 101. Resilience Key News & Latest Developments
Table 102. BioCentriq Company Summary
Table 103. BioCentriq Cell and Gene Therapy Manufacturing Services Product Offerings
Table 104. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 105. BioCentriq Key News & Latest Developments
Table 106. Porton Biopharma Limited Company Summary
Table 107. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Product Offerings
Table 108. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 109. Porton Biopharma Limited Key News & Latest Developments
Table 110. Andelyn Biosciences Company Summary
Table 111. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Product Offerings
Table 112. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 113. Andelyn Biosciences Key News & Latest Developments
Table 114. Commercializing Living Therapies Company Summary
Table 115. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Product Offerings
Table 116. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 117. Commercializing Living Therapies Key News & Latest Developments
Table 118. Vibalogics Company Summary
Table 119. Vibalogics Cell and Gene Therapy Manufacturing Services Product Offerings
Table 120. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 121. Vibalogics Key News & Latest Developments
Table 122. Anemocyte Srl Company Summary
Table 123. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Product Offerings
Table 124. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 125. Anemocyte Srl Key News & Latest Developments
Table 126. ElevateBio Company Summary
Table 127. ElevateBio Cell and Gene Therapy Manufacturing Services Product Offerings
Table 128. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue (US$, Mn) & (2018-2023)
Table 129. ElevateBio Key News & Latest Developments
List of Figures
Figure 1. Cell and Gene Therapy Manufacturing Services Segment by Type in 2022
Figure 2. Cell and Gene Therapy Manufacturing Services Segment by Application in 2022
Figure 3. Global Cell and Gene Therapy Manufacturing Services Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cell and Gene Therapy Manufacturing Services Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cell and Gene Therapy Manufacturing Services Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell and Gene Therapy Manufacturing Services Revenue in 2022
Figure 8. By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 9. By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 10. By Type - Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 12. By Application - Global Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 14. By Region - Global Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 15. By Country - North America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 16. US Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 20. Germany Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 21. France Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 28. China Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 32. India Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 34. Brazil Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Cell and Gene Therapy Manufacturing Services Revenue Market Share, 2018-2029
Figure 37. Turkey Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Cell and Gene Therapy Manufacturing Services Revenue, (US$, Mn), 2018-2029
Figure 41. Thermo Fisher Scientific Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck KGaA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Charles River Laboratories Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Lonza Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Catalent Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. WuXi AppTec Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Takara Bio Inc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Nikon Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. FUJIFILM Holdings Corporation Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. F. Hoffmann-La Roche Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Oxford Biomedica Plc Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Cell and Gene Therapy Catapult Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. The Discovery Labs LLC Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. RoslinCT Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. JRS PHARMA Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. FinVector Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. ABL Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. Resilience Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. BioCentriq Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Porton Biopharma Limited Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Andelyn Biosciences Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Commercializing Living Therapies Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Vibalogics Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Anemocyte Srl Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. ElevateBio Cell and Gene Therapy Manufacturing Services Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
